Autoimmune mechanisms activating the angiotensin AT1 receptor in 'primary' aldosteronism

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 5, 2014, Pages 1790-1797

  Kem, David C ^a   Li, Hongliang ^a   Velarde Miranda, Carolina ^c   Liles, Campbell ^a   Vanderlinde Wood, Megan ^a,b   Galloway, Allison ^a   Khan, Muneer ^a   Zillner, Caitlin ^a   Benbrook, Alexandria ^a   Rao, Veitla ^a   Gomez Sanchez, Celso E ^c   Cunningham, Madeleine W ^b   Yu, Xichun ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; AUTOANTIBODY; IMMUNOGLOBULIN G;

ADRENAL CELL; ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE DETERMINATION; HUMAN; IN VITRO STUDY; MALE; MIDDLE AGED; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ADULT; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ARTERIOLES; AUTOANTIBODIES; AUTOIMMUNITY; CELL LINE, TUMOR; FEMALE; HUMANS; HYPERALDOSTERONISM; LOSARTAN; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84899896751     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-3282     Document Type: Article

References (30)

1. Conn JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955;45: 3-17.
2. Weinberger MH, Grim CE, Hollifield JW, et al. Primary aldosteronism: diagnosis, localization, and treatment. Ann Intern Med. 1979;90:386-395.
3. Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med. 2001;135:258-261.
4. Ferriss JB, Brown JJ, Fraser R, et al. Results of adrenal surgery in patients with hypertension, aldosterone excess, and low plasma renin concentration. Br Med J. 1975;1:135-138.
5. Weigel RJ, Wells SA, Gunnells JC, Leight GS. Surgical treatment of primary hyperaldosteronism. Ann Surg. 1994;219:347-352.
6. Banks WA, Kastin AJ, Biglieri EG, Ruiz AE. Primary adrenal hyperplasia: a new subset of primary hyperaldosteronism. J Clin Endocrinol Metab. 1984;58:783-785.
7. Katz FH. Primary aldosteroni sm with suppressed plasma renin activity due to bilateral nodular adrenocortical hyperplasia. Ann Intern Med. 1967;67:1035-1042.
8. Longo DL, Esterly JA, Grim CE, Keitzer WF. Pathology of the adrenal gland in refractory low-renin hypertension. Arch Pathol Lab Med. 1978;102:322-327.
9. Biglieri EG Schambelan M Slaton PE Stockigt JR. The intercurrent hypertension of primary aldosteronism Circ Res. 1970 27 195-202.
10. Baer L, Sommers SC, Krakoff LR, Newton MA, Laragh JH. Pseudoprimary aldosteronism. An entity distinct from true primary aldosteronism. Circ Res. 1970;27:203-220.
11. Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 1999;103:945-952.
12. Dragun D, Muller DN, Brasen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med. 2005;352:558-569.
13. Fu ML, Herlitz H, Schulze W, et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens. 2000;18:945-953.
14. Choi M, Scholl U I, Yue P, et al. K-channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772.
15. Rossitto G, Regolisti G, Rossi E, et al. Elevation of angiotensin-II type-1-receptor autoantibodies titer in primary aldosteronism as a result of aldosterone-producing adenoma. Hypertension. 2013;61: 526-533.
16. Lyons DF, Kem DC, Brown RD, Hanson CS, Carollo ML. Single dose captopril as a diagnostic test for primary aldosteronism. J Clin Endocrinol Metab. 1983;57:892-896.
17. Kem DC, Weinberger MH, Mayes DM, Nugent CA. Saline suppression of plasma aldosterone in hypertension. Arch Intern Med. 1971;128:380-386.
18. Li H, Kem DC, Reim S, Vanderlinde-Wood M, et al. Agonistic autoantibodies as vasodilators in orthostatic hypotension: a new mechanism. Hypertension. 2012;59:402-408.
19. Wang T, Rowland JG, Parmar J, Nesterova M, Seki T, Rainey WE. Comparison of aldosterone production among human a drenocortical cell lines. Horm Metab Res. 2012;44:245-250.
20. Oki K, Kopf PG, Campbell WB, Luis Lam M, Yamazaki T, Gomez-Sanchez CE, Gomez-Sanchez EP. Angiotensin II and III met abolism and effects on steroid production in the HAC15 human adrenocortical cell line. Endocrinology. 2013;154:214-221.
21. Azizan EA, Murthy M, Stowasser M, et al. Somatic mutations affecting t he selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas. Hypertension. 2012; 59:587-591.
22. Oki K, Plonczynski MW, Luis Lam M, Gomez-Sanchez EP, G omez-Sanchez CE. Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis. Endocrinology. 2012;153:1774-1782.
23. Torpy DJ, Gordon RD, Lin JP, et al. Familial hyperaldosteronism type II: description of a large kindred and exclusion of the aldosterone synthase (CYP11B2) gene. J Clin Endocrinol Metab. 1998;83: 3214-3218.
24. Dragun D, Philippe A, Catar R , Hegner B. Autoimmune mediated G-protein receptor activation in cardiovascular and renal pathologies. Thromb Haemost. 2009;101:643-648.
25. May LT, Leach K, Sexton PM, Christopoulos A. Allosteric modulation of G protein-coupled receptors. Annu Rev Pharmacol Toxicol. 2007;47:1-51.
26. Li H,YuX, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014;3:e000755.
27. Wisgerhof M, Brown RD, Hogan MJ, Carpenter PC, Edis AJ. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J Clin Endocrinol Metab. 1981;52:195-198.
28. Iwata M, Yoshikawa T, Baba A, et al. Autoimmunity against the second extracellular loop of-(1)-adrenergic receptors induces-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ Res. 2001;88:578-586.
29. Tunny TJ, Gordon RD, Klemm SA, Cohn D. Histological and biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin. Clin Endocrinol (Oxf). 1991;34:363-369.
30. Li Y Heuser JS Cunningham LC Kosanke SD Cunningham MW. Mimicry and antibody-mediated cell signaling in autoimmune myocarditis J Immunol. 2006 177 8234-8240.